别名 |
PX-13-17OH;Cyclopenta[5,6]naphtho[1,2-c]pyran-2,10(1H,4H)-dione, 5-(acetyloxy)-1-[[[3-(dimethylamino)propyl]methylamino]methylene]-4a,5,6,6a,7,8,9,9a-octahydro-7,11-dihydroxy-4-(methoxymethyl)-4a,6a-dimethyl-, (1E,4S,4aR,5R,6aS,7S,9aR)-;(1E,4S,4aR,5R,6aS,7S,9aR)-5-(acetyloxy)-1-[[[3-(dimethylamino)propyl]methylamino]methylene]-4a,5,6,6a,7,8,9,9a-octahydro-cyclopenta[5,6]naphtho[1,2-c]pyran-2,10(1H,4H)-dione;[(1S,3aR,6E,9S,9aR,10R,11aS)-6-[[3-(Dimethylamino)propyl-methylamino]methylidene]-1,5-dihydroxy-9-(methoxymethyl)-9a,11a-dimethyl-4, 7-dioxo-2,3,3a,9,10,11-hexahydro-1H-indeno[4,5-H]isochromen-10-yl] acetate |
标准英文名 |
(4S,4aR,5R,6aS,7S,9aR,E)-1-(((3-(dimethylamino)propyl)(methyl)amino)methylene)-7,11-dihydroxy-4-(methoxymethyl)-4a,6a-dimethyl-2,10-dioxo-1,2,4,4a,5,6,6a,7,8,9,9a,10-dodecahydroindeno[4,5-h]isochromen-5-yl acetate |
用途 |
PX-13-17OH is a PI3K inhibitor that selectively inhibits PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ (IC50s = 6.4, 13, 8, and 11 nM, respectively) over mTOR (IC50 = 2.9 μM); it exhibits more than 420-fold selectivity for PI3K over a panel of 20 lipid and protein kinases; it suppresses phosphorylation of Akt and S6 kinase (S6K) in PTEN-negative U87MG cells at concentrations ranging from 0.03 to 1 μg/mL; and it inhibits tumor growth in a U87MG mouse xenograft model at doses ranging from 2.5 to 10 mg/kg. |